Egrifta Side Effects
Generic name: tesamorelin
Medically reviewed by Drugs.com. Last updated on Jul 24, 2024.
Note: This document provides detailed information about Egrifta Side Effects associated with tesamorelin. Some dosage forms listed on this page may not apply specifically to the brand name Egrifta.
Applies to tesamorelin: subcutaneous powder for solution.
Serious side effects of Egrifta
Along with its needed effects, tesamorelin (the active ingredient contained in Egrifta) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking tesamorelin:
More common side effects
- difficulty with moving
- muscle pain or stiffness
- pain in the arms or legs
- pain in the joints
Less common side effects
- blurred vision
- burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- burning, numbness, pain, or tingling in all fingers except the smallest finger
- chest pain
- dizziness
- fast, irregular, pounding, or racing heartbeat or pulse
- headache
- nervousness
- pounding in the ears
- slow or fast heartbeat
- swelling of the joints
- unsteadiness or awkwardness
- weakness in the arms, hands, legs, or feet
Other side effects of Egrifta
Some side effects of tesamorelin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at injection site
- muscle aching or cramping
Less common side effects
- acid or sour stomach
- belching
- bone pain
- discouragement
- feeling of warmth
- feeling sad or empty
- heartburn
- indigestion
- irritability
- itching skin
- lack of appetite
- loss of interest or pleasure
- muscle spasms
- nausea
- night sweats
- rash
- redness of the face, neck, arms, and occasionally, upper chest
- sleeplessness
- stiffness of the joints
- stomach discomfort, upset, or pain
- strain in the muscles
- sudden sweating
- tiredness
- trouble concentrating
- trouble sleeping
- unable to sleep
- upper abdominal or stomach pain
- vomiting
For healthcare professionals
Applies to tesamorelin: subcutaneous powder for injection.
Musculoskeletal adverse events
- Very common (10% or more): Arthralgia (13.3%)
- Common (1% to 10%): Pain in extremity, myalgia, musculoskeletal pain, musculoskeletal stiffness, joint stiffness, muscle spasms, joint swelling, muscle strain[Ref]
Local
- Common (1% to 10%): Injection site erythema, injection site pruritus, injection site pain, injection site irritation, injection site hemorrhage, injection site urticaria, injection site swelling, injection site reaction, injection site rash[Ref]
Nervous system
- Common (1% to 10%): Paresthesia, hypoesthesia, carpal tunnel syndrome, peripheral neuropathy[Ref]
Gastrointestinal
Metabolic
- Common (1% to 10%): Diabetes
- Uncommon (0.1% to 1%): Increased HbA1c[Ref]
Cardiovascular
- Common (1% to 10%): Palpitations, hypertension, hot flush[Ref]
Psychiatric
- Common (1% to 10%): Depression, insomnia[Ref]
Dermatologic
- Common (1% to 10%): Rash, pruritus, night sweats[Ref]
Other
- Common (1% to 10%): Peripheral edema, pain, chest pain, blood creatine phosphokinase increased
Immunologic
- Very common (10% or more): Anti- tesamorelin (the active ingredient contained in Egrifta) IgG antibodies (49.5%)
References
1. (2010) "Product Information. Egrifta (tesamorelin)." Theratechnologies Inc.
More about Egrifta (tesamorelin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (20)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Egrifta side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.